Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing, Hereditary Non-Cancer Testing; By Technology; By Regions; Segment Forecast, 2020

The global hereditary testing market expected to reach USD 9.29 billion by 2027 according to this new study. The report “Hereditary Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Hereditary Cancer Testing, Hereditary Non-Cancer Testing; By Technology (Cytogenetic, Biochemical, Molecular Testing); By Regions; Segment Forecast, 2020-2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing need for timely diagnosis of genetic hereditary diseases and launch of cost-effective treatment options by the key players are the key factors responsible for market growth. According to the market statistics published by the organization dedicated for the rare diseases, over 300 million people are currently suffering from around 6,000 identified forms of rare disorders worldwide.

Technological advancements in the marketspace and use of cloud-based distribution model for laboratories to avail the bioinformatics is expected to have a positive impact on the hereditary testing growth. Furthermore, the increasing test volumes for genetic tests across the developed economies is expected to drive market demand for hereditary testing over the forecast period.

Segment Highlights
The hereditary cancer testing market segment accounted for the largest revenue segment in 2019 owing to the increasing genetic tests for cancer in developed economies such as the U.S., UK, Canada, and France, among others
Europe market accounted for the largest revenue share in 2019 owing to the increasing tests across the region and technological advancement in the field of testing is expected to drive the market growth of hereditary tests over the forecast period

List of Key Players
Myriad Genetics, Inc.
Invitae Corporation
Illumina, Inc.
Natera, Inc.
Hoffmann-La Roche Ltd
Quest Diagnostics
Agilent Technologies, Inc.
Twist Bioscience
Sophia Genetics
Fulgent Genetic, Inc.
Medgenome
CENTOGENE N.V.
Others

The publisher has segmented the hereditary testing market report on the basis of disease type, technology, and region

Hereditary Testing, Disease Type Outlook (Revenue-USD Million, 2016-2027)

Hereditary Cancer Testing
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Ovarian Cancer
Prostate Cancer
Stomach/Gastric Cancer
Melanoma
Sarcoma
Uterine Cancer
Pancreatic Cancer
Others
Hereditary Non-Cancer Testing
Genetic Tests
Cardiac Diseases
Rare Diseases
Other Diseases
Newborn Genetic Screening
Preimplantation Genetic Diagnosis & Screening

Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

Hereditary Testing, Technology Outlook (Revenue-USD Million, 2016-2027)

Cytogenetic Testing
Biochemical Testing
Molecular Testing

Hereditary Testing Regional Outlook (Revenue-USD Million, 2016-2027)

North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Central & South America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

Frequently Asked Questions about the Hereditary Testing Market

What is the estimated value of the Hereditary Testing Market?

The Hereditary Testing Market was estimated to be valued at $5.78 Billion in 2020.

What is the growth rate of the Hereditary Testing Market?

The growth rate of the Hereditary Testing Market is 6.2%, with an estimated value of $9.29 Billion by 2027.

What is the forecasted size of the Hereditary Testing Market?

The Hereditary Testing Market is estimated to be worth $9.29 Billion by 2027.

Who are the key companies in the Hereditary Testing Market?

Key companies in the Hereditary Testing Market include Myriad Genetics Inc., Natera Inc., F. Hoffmann, La Roche Ltd, Invitae Corporation, Illumina Inc., Fulgent Genetic Inc., Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc. and Twist Bioscience.

Report Attribute	Details
No. of Pages	121
Published	December 2020
Forecast Period	2020 - 2027
Estimated Market Value ( USD ) in 2020	$ 5.78 Billion
Forecasted Market Value ( USD ) by 2027	$ 9.29 Billion
Compound Annual Growth Rate	6.2%
Regions Covered	Global
No. of Companies Mentioned	13

1. Introduction

1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Hereditary Testing Market Insights

4.1. Hereditary Testing - Industry snapshot
4.2. Hereditary Testing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rapid innovations in the hereditary testing
4.2.1.2. Growing prevalence of hereditary diseases
4.2.2. Restraints and Challenges
4.2.2.1. Efficacy of the testing
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Hereditary Testing Market Industry trends

5. Hereditary Testing Market Assessment by Disease Type

5.1. Key Findings
5.2. Introduction
5.2.1. Global Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
5.3. Hereditary Cancer Testing
5.3.1. Global Hereditary Testing Market, by Hereditary Cancer Testing, by Region, 2016 - 2027 (USD Million)
5.3.2. Lung Cancer
5.3.2.1. Hereditary Cancer Testing, for Lung Cancer, 2016 - 2027 (USD Million)
5.3.3. Breast Cancer
5.3.3.1. Hereditary Cancer Testing, for Breast Cancer, 2016 - 2027 (USD Million)
5.3.4. Colorectal Cancer
5.3.4.1. Hereditary Cancer Testing, for Colorectal Cancer, 2016 - 2027 (USD Million)
5.3.5. Cervical Cancer
5.3.5.1. Hereditary Cancer Testing, for Cervical Cancer, 2016 - 2027 (USD Million)
5.3.6. Ovarian Cancer
5.3.6.1. Hereditary Cancer Testing, for Ovarian Cancer, 2016 - 2027 (USD Million)
5.3.7. Prostate Cancer
5.3.7.1. Hereditary Cancer Testing, for Prostate Cancer, 2016 - 2027 (USD Million)
5.3.8. Stomach/Gastric Cancer
5.3.8.1. Hereditary Cancer Testing, for Stomach/Gastric Cancer, 2016 - 2027 (USD Million)
5.3.9. Melanoma
5.3.9.1. Hereditary Cancer Testing, for Melanoma, 2016 - 2027 (USD Million)
5.3.10. Sarcoma
5.3.10.1. Hereditary Cancer Testing, for Sarcoma, 2016 - 2027 (USD Million)
5.3.11. Uterine Cancer
5.3.11.1. Hereditary Cancer Testing, for Uterine Cancer, 2016 - 2027 (USD Million)
5.3.12. Pancreatic Cancer
5.3.12.1. Hereditary Cancer Testing, for Pancreatic Cancer, 2016 - 2027 (USD Million)
5.3.13. Others
5.3.13.1. Hereditary Cancer Testing, for Other Cancer, 2016 - 2027 (USD Million)
5.4. Hereditary Non-Cancer Testing
5.4.1. Global Hereditary Testing Market, by Hereditary Non-Cancer Testing, by Region, 2016 - 2027 (USD Million)
5.4.2. Non-cancer Genetic Tests
5.4.2.1. Hereditary non-cancer genetic testing market, 2016 - 2027 (USD Million)
5.4.2.2. Cardiac Diseases
5.4.2.2.1. Hereditary non-cancer genetic testing market for Cardiac Diseases, 2016 - 2027 (USD Million)
5.4.2.3. Rare Diseases
5.4.2.3.1. Hereditary non-cancer genetic testing market for Rare Diseases, 2016 - 2027 (USD Million)
5.4.2.4. Other Diseases
5.4.2.4.1. Hereditary non-cancer genetic testing market for Other Diseases, 2016 - 2027 (USD Million)
5.4.3. Newborn Genetic Screening
5.4.3.1. Hereditary Newborn Genetic Screening market, 2016 - 2027 (USD Million)
5.4.4. Preimplantation Genetic Diagnosis & Screening
5.4.4.1. Hereditary Preimplantation Genetic Diagnosis & Screening market, 2016 - 2027 (USD Million)
5.4.5. Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
5.4.5.1. Hereditary Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests market, 2016 - 2027 (USD Million)

6. Global Hereditary Testing Market, by Technology

6.1. Key Findings
6.2. Introduction
6.2.1. Global Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
6.3. Cytogenetic
6.3.1. Global Hereditary Testing Market, by Cytogenetic, By Region, 2016 - 2027 (USD Million)
6.4. Biochemical
6.4.1. Global Hereditary Testing Market, by Biochemical, by Region, 2016 - 2027 (USD Million)
6.5. Molecular Testing
6.5.1. Global Hereditary Testing Market, by Molecular Testing, by Region, 2016 - 2027 (USD Million)

7. Hereditary Testing Market Assessment by Geography

7.1. Key findings
7.2. Introduction
7.2.1. Hereditary Testing Market Assessment, By Geography, 2016 - 2027 (USD Million)
7.3. Hereditary Testing Market - North America
7.3.1. North America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.3.2. North America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.3.3. Hereditary Testing Market - U. S.
7.3.3.1. U. S.: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.3.3.2. U. S.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.3.4. Hereditary Testing Market - Canada
7.3.4.1. Canada: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.3.4.2. Canada.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4. Hereditary Testing Market - Europe
7.4.1. Europe: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.2. Europe: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4.3. Hereditary Testing Market - UK
7.4.3.1. UK: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.3.2. UK: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4.4. Hereditary Testing Market - France
7.4.4.1. France: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.4.2. France: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4.5. Hereditary Testing Market - Germany
7.4.5.1. Germany: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.5.2. Germany: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4.6. Hereditary Testing Market - Italy
7.4.6.1. Italy: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.6.2. Italy: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4.7. Hereditary Testing Market - Spain
7.4.7.1. Spain: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.7.2. Spain: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4.8. Hereditary Testing Market - Netherlands
7.4.8.1. Netherlands: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.8.2. Netherlands: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.4.9. Hereditary Testing Market - Austria
7.4.9.1. Austria: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.4.9.2. Austria: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.5. Hereditary Testing Market - Asia-Pacific
7.5.1. Asia Pacific: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.5.2. Asia Pacific: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.5.3. Hereditary Testing Market - China
7.5.3.1. China: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.5.3.2. China: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.5.4. Hereditary Testing Market - India
7.5.4.1. India: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.5.4.2. India.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.5.5. Hereditary Testing Market - Malaysia
7.5.5.1. Malaysia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.5.5.2. Malaysia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.5.6. Hereditary Testing Market - Japan
7.5.6.1. Japan: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.5.6.2. Japan: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.5.7. Hereditary Testing Market - Indonesia
7.5.7.1. Indonesia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.5.7.2. Indonesia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.5.8. Hereditary Testing Market - South Korea
7.5.8.1. South Korea: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.5.8.2. South Korea.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.6. Hereditary Testing Market - Middle East & Africa
7.6.1. Middle East & Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.6.2. Middle East & Africa.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.6.3. Hereditary Testing Market - Saudi Arabia
7.6.3.1. Saudi Arabia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.6.3.2. Saudi Arabia.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.6.4. Hereditary Testing Market - UAE
7.6.4.1. UAE: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.6.4.2. UAE: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.6.5. Hereditary Testing Market - Israel
7.6.5.1. Israel: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.6.5.2. Israel: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.6.6. Hereditary Testing Market - South Africa
7.6.6.1. South Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.6.6.2. South Africa: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.7. Hereditary Testing Market - Latin America
7.7.1. Latin America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.7.2. Latin America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.7.3. Hereditary Testing Market - Mexico
7.7.3.1. Mexico: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.7.3.2. Mexico.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.7.4. Hereditary Testing Market - Brazil
7.7.4.1. Brazil: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.7.4.2. Brazil.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
7.7.5. Hereditary Testing Market - Argentina
7.7.5.1. Argentina: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
7.7.5.2. Argentina.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Myriad Genetics, Inc.
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product/Services Benchmarking
9.1.4. Recent Development
9.2. Invitae Corporation
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product/Services Benchmarking
9.2.4. Recent Development
9.3. Illumina, Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product/Services Benchmarking
9.3.4. Recent Development
9.4. Natera, Inc.
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product/Services Benchmarking
9.4.4. Recent Development
9.5. F. Hoffmann-La Roche Ltd
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product/Services Benchmarking
9.5.4. Recent Development
9.6. Quest Diagnostics Incorporated
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product/Services Benchmarking
9.6.4. Recent Development
9.7. Agilent Technologies, Inc.
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product/Services Benchmarking
9.7.4. Recent Development
9.8. Twist Bioscience Inc.
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product/Services Benchmarking
9.8.4. Recent Development
9.9. Sophia Genetics
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product/Services Benchmarking
9.9.4. Recent Development
9.10. Fulgent Genetics
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product/Services Benchmarking
9.10.4. Recent Development

List of Tables

Table 1. Global Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 2. Global Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 3. Hereditary Testing Market Assessment, By Geography, 2016 - 2027 (USD Million)
Table 4. North America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 5. North America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 6. U.S.: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 7. U.S.: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 8. Canada: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 9. Canada: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 10. Europe: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 11. Europe: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 12. UK: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 13. UK: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 14. France: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 15. France: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 16. Germany: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 17. Germany: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 18. Italy: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 19. Italy: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 20. Spain: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 21. Spain: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 22. Netherlands: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 23. Netherlands: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 24. Austria: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 25. Austria: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 26. Asia Pacific: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 27. Asia Pacific: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 28. China: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 29. China: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 30. India: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 31. India: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 32. Malaysia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 33. Malaysia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 34. Japan: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 35. Japan: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 36. Indonesia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 37. Indonesia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 38. South Korea: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 39. South Korea: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 40. Middle East & Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 41. Middle East & Africa: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 42. Saudi Arabia: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 43. Saudi Arabia: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 44. UAE: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 45. UAE: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 46. Israel: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 47. Israel: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 48. South Africa: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 49. South Africa: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 50. Latin America: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 51. Latin America: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 52. Mexico: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 53. Mexico: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 54. Brazil: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 55. Brazil: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)
Table 56. Argentina: Hereditary Testing Market, By Disease Type, 2016 - 2027 (USD Million)
Table 57. Argentina: Hereditary Testing Market, By Technology, 2016 - 2027 (USD Million)

List of Figures

Figure 1 Market Highlights (2019, Revenue)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top Down & Bottom Up Approach
Figure 4 Market by Geography
Figure 5 Porter’s Five Forces
Figure 6 Market by Disease Type
Figure 7 Global Hereditary Testing Market, By Disease Type, 2019 & 2027 (USD Million)
Figure 8 Market by Technology
Figure 9 Global Hereditary Testing Market, By Technology, 2019 & 2027 (USD Million)
Figure 10 Hereditary Testing Market Assessment, By Geography, 2016 - 2027 (USD Million)
Figure 11 Strategic Analysis - Hereditary Testing Market